Author: Baay, Marc; Neels, Pieter
Title: SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues Cord-id: hcphw6ka Document date: 2020_8_15
ID: hcphw6ka
Snippet: This second International Alliance for Biological Standardization COVID-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable participation from low- and middle-income countries, to discuss the use of controlled human infection models to accelerate development and market authorization assessment of a vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Document: This second International Alliance for Biological Standardization COVID-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable participation from low- and middle-income countries, to discuss the use of controlled human infection models to accelerate development and market authorization assessment of a vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Search related documents:
Co phrase search for related documents- absence presence and adjuvant vaccine: 1, 2, 3
- absence presence and living people: 1, 2, 3, 4, 5
- absence presence and low mutation: 1
- absence presence and low possible: 1
- academic private and access information: 1, 2
- academic private and living people: 1
- academic private and low possible: 1
Co phrase search for related documents, hyperlinks ordered by date